Search results
Results from the WOW.Com Content Network
Novo Holdings A/S (formerly Novo A/S) [1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation 's assets, which in 2023 was worth almost DKK 1,114 billion [ 2 ] [ 3 ] [ 4 ] Danish Kroner (approximately US$163 billion).
The Novo Nordisk Foundation is obligated to maintain its controlling ownership in the Novo Group's two largest companies: Novo Nordisk and Novozymes. The foundation owns class A and B-shares in Novo Nordisk corresponding to approximately 28 percent of the total equity and approximately 75 percent of the total voting rights.
Kasim Kutay (born 13 May 1965) is a British fund manager who is the CEO of Danish Novo Holdings A/S, an investment fund that manages investments and assets for the Novo Nordisk Foundation. He holds British citizenship and resides in Denmark. Kasim Kutay was a investment banker, focusing on the healthcare sector. [1]
Novo Nordisk Foundation's nine-person board includes former Novo CEO and current board chairman Lars Rebien Sørensen, University of Copenhagen professor Liselotte Højgaard, Massachusetts ...
The Novo Nordisk Foundation has become a major philanthropic force as a result, with Novo Holdings’ €149 billion ($156 billion) in assets under management dwarfing the $75.2 billion endowment ...
Novo Holdings, the investment arm of Novo's controlling shareholder, the Novo Nordisk Foundation, will buy Catalent's shares for $11.5 billion before including debt.
The Novo Nordisk Foundation is one of the largest foundations in the world and the foundation which is the majority shareholder in Novo Nordisk, Novozymes and NNIT (Novo Group) along with investments in more than 80 other companies within the life-sciences sector through its 100% owned subsidiary Novo Holdings A/S.
The company, the investment arm of the Novo Nordisk Foundation, has 77% of voting shares in Novo Nordisk that makes the blockbuster obesity drug Wegovy and diabetes treatment Ozempic. Novo ...